Cargando…
Sortase-Mediated Site-Specific Modification of Interleukin-2 for the Generation of a Tumor-Targeting Acetazolamide–Cytokine Conjugate
[Image: see text] Small ligands specific to tumor-associated antigens can be used as alternatives to antibodies for the delivery of small payloads such as radionuclides, cytotoxic drugs, and fluorophores. Their use as a delivery moiety of bioactive proteins such as cytokines remains largely unexplor...
Autores principales: | Gouyou, Baptiste, Millul, Jacopo, Villa, Alessandra, Cazzamalli, Samuele, Neri, Dario, Matasci, Mattia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558062/ https://www.ncbi.nlm.nih.gov/pubmed/33073134 http://dx.doi.org/10.1021/acsomega.0c03592 |
Ejemplares similares
-
Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade
por: Dakhel, Sheila, et al.
Publicado: (2019) -
In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin
Conjugate for the Treatment of Renal Cell Carcinoma
por: Cazzamalli, Samuele, et al.
Publicado: (2018) -
In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin
Conjugate for the Treatment of Renal Cell Carcinomas
por: Cazzamalli, Samuele, et al.
Publicado: (2018) -
An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease
por: Dakhel, Sheila, et al.
Publicado: (2021) -
Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension
por: Gouyou, Baptiste, et al.
Publicado: (2021)